Secrest Blakey & Associates’s Amgen AMGN Stock Holding History

Secrest Blakey & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$691K	Sell	2,718 -3	-0.1%	-$743	1.58%	23
2020 Q2	$642K	Buy	2,721 +4	+0.1%	+$913	1.55%	25
2020 Q1	$551K	Sell	2,717 -6	-0.2%	-$1.31K	1.5%	26
2019 Q4	$656K	Sell	2,723 -2,728	-50%	-$601K	1.44%	29
2019 Q3	$1.05M	Buy	5,451 +87	+2%	+$16.7K	0.87%	33
2019 Q2	$989K	Buy	5,364 +624	+13%	+$112K	0.86%	34
2019 Q1	$901K	Sell	4,740 -1,375	-22%	-$263K	0.88%	34
2018 Q4	$1.19M	Buy	6,115 +82	+1%	+$16K	1%	28
2018 Q3	$1.25M	Sell	6,033 -51	-0.8%	-$10.1K	0.96%	30
2018 Q2	$1.12M	Buy	6,084 +427	+8%	+$75.5K	0.88%	31
2018 Q1	$964K	Buy	+5,657	New	+$1.04M	0.82%	30

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Secrest Blakey & Associates's AMGN Position: Q3 2020 in Review

Secrest Blakey & Associates reduced its Amgen (AMGN) stake by 0.11% in Q3 2020, selling an estimated $743 and leaving 2,718 shares worth $691K. The position accounts for 1.58% of the portfolio, ranked #23.

Secrest Blakey & Associates first reported a position in AMGN in Q1 2018 and has held it in 11 quarters since. The position peaked at $1.25M in Q3 2018. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

Secrest Blakey & Associates held 2,718 shares of Amgen worth $691K as of Q3 2020.
Secrest Blakey & Associates sold 3 Amgen shares in Q3 2020, an estimated $743.
Amgen made up 1.58% of Secrest Blakey & Associates's portfolio in Q3 2020, its #23 holding.
Secrest Blakey & Associates first reported a position in Amgen in Q1 2018 and has held it in 11 quarters since.
Secrest Blakey & Associates's Amgen position peaked at $1.25M in Q3 2018.
2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Secrest Blakey & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.